Recommended for you
Home / Poster / Prediction of mAb disposition in hepatic impairment – Evolocumab as a case study
Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.
© 2025 Certara. All Rights Reserved. | Privacy policy
